Biograil is a biotech company manufacturing an oral device for delivery of biologics
Biograil has raised $10.0M in total funding. The most recent round was Seed. The last funding was announced in July 2025.
Biograil's investors include HTGF (High-Tech Gruenderfonds), Verve Ventures, Acandis, Arve Capital, Megatrend Invest.
Biograil is headquartered in Copenhagen, Denmark.
Biograil is a biotech company manufacturing an oral device for delivery of biologics
Biograil is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biograil — Funding & Investors." VCBacked, July 1, 2025, https://www.vcbacked.co/company/biograil. Accessed July 20, 2026.
VCBacked. (2025). Biograil — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/biograil
{{cite web |title=Biograil — Funding & Investors |url=https://www.vcbacked.co/company/biograil |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated